- Home
- TNGX vs LANV Comparison
TNGX vs LANV Comparison
Compare TNGX & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- LANV
- Stock Information
- Founded
- TNGX 2014
- LANV 2015
- Country
- TNGX United States
- LANV China
- Employees
- TNGX N/A
- LANV N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- LANV Blank Checks
- Sector
- TNGX Health Care
- LANV Finance
- Exchange
- TNGX Nasdaq
- LANV Nasdaq
- Market Cap
- TNGX 317.4M
- LANV 258.1M
- IPO Year
- TNGX N/A
- LANV N/A
- Fundamental
- Price
- TNGX $1.14
- LANV $2.47
- Analyst Decision
- TNGX Strong Buy
- LANV
- Analyst Count
- TNGX 7
- LANV 0
- Target Price
- TNGX $12.33
- LANV N/A
- AVG Volume (30 Days)
- TNGX 532.3K
- LANV 48.3K
- Earning Date
- TNGX 05-12-2025
- LANV 04-30-2025
- Dividend Yield
- TNGX N/A
- LANV N/A
- EPS Growth
- TNGX N/A
- LANV N/A
- EPS
- TNGX N/A
- LANV N/A
- Revenue
- TNGX $42,069,000.00
- LANV $340,211,202.00
- Revenue This Year
- TNGX N/A
- LANV $11.74
- Revenue Next Year
- TNGX N/A
- LANV $11.11
- P/E Ratio
- TNGX N/A
- LANV N/A
- Revenue Growth
- TNGX 15.17
- LANV N/A
- 52 Week Low
- TNGX $1.11
- LANV $0.91
- 52 Week High
- TNGX $12.02
- LANV $2.66
- Technical
- Relative Strength Index (RSI)
- TNGX 36.06
- LANV 67.05
- Support Level
- TNGX $1.03
- LANV $1.71
- Resistance Level
- TNGX $1.56
- LANV $2.12
- Average True Range (ATR)
- TNGX 0.15
- LANV 0.16
- MACD
- TNGX -0.01
- LANV 0.03
- Stochastic Oscillator
- TNGX 17.74
- LANV 100.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.